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Abstract
Disease-causing variants of a large number of genes trigger inherited retinal degeneration leading to photoreceptor
loss. Because cones are essential for daylight and central vision such as reading, mobility, and face recognition,
this review focuses on a variety of animal models for cone diseases. The pertinence of using these models to reveal
genotype/phenotype correlations and to evaluate new therapeutic strategies is discussed. Interestingly, several
large animal models recapitulate human diseases and can serve as a strong base from which to study the biology
of disease and to assess the scale-up of new therapies. Examples of innovative approaches will be presented such
as lentiviral-based transgenesis in pigs and adeno-associated virus (AAV)-gene transfer into the monkey eye to
investigate the neural circuitry plasticity of the visual system. The models reported herein permit the exploration
of common mechanisms that exist between different species and the identification and highlighting of pathways
that may be specific to primates, including humans.
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The importance of cones for vision
Human vision is based on three systems of photosensi-
tivity: (1) rod photoreceptors, (2) cone photoreceptors,
and (3) melanopsin-expressing retinal ganglion cells.
Together, these photosensitive cells cover 12 log of light
intensity units [1]. Rod photoreceptor cells are respon-
sible for the detection of stimuli in dim light, whereas
cone photoreceptor cells transmit visual information in
bright light conditions. Melanopsin-expressing retinal
ganglion cells are also sensitive to bright light, and
are implicated in non-image-forming visual functions
such as circadian synchronization or pupillary light
reflexes. Cones also provide colour vision and high
visual acuity, allowing precise tasks such as reading
or facial recognition. Phototransduction occurs in the
long process of photoreceptor cells, termed the outer
segment (OS), that is linked to the cell body by the
inner segment (IS), which contains mitochondria.
Without neglecting the heavy consequences of rod loss
for vision (night blindness, for example), loss of the
cone system is dramatic in our highly technological
world, where reading and visual communication are
extremely important for social interactions. Moreover,
in patients suffering from rod deficiency, a secondary
death of cones is observed which definitely worsens
their quality of life. To date, no molecular therapy has
been successful in stopping cone degeneration, and
physicians can only encourage patients to adapt to their
vision loss or propose diets that might slow the process
in certain conditions [2]. Thus, the study of cone degen-
eration mechanisms and the examination of innovative
therapeutic strategies are a major field of research in
ophthalmology.
Very good reviews on retinal dystrophies, includ-
ing cone dystrophies, were recently published and we
encourage the reader to refer to these works for an
exhaustive documentation [3–5]. The present review
focuses mainly on genetically modified models and
summarizes the naturally occurring models for pro-
nounced cone dystrophies (Table 1).
In vitro modelling of cone photoreceptors
The development of induced pluripotent stem cells
(iPSCs) has brought new opportunities to dissect in
vitro the molecular mechanisms of cone degeneration.
Fibroblasts or blood cells may be reprogrammed using
four key genes (Oct3/4, Sox2, Klf4, and c-Myc) to
acquire an embryonic stem cell-like stage [6] which is
characterized by pluripotency. These cells, or embryonic
stem cells, can then be differentiated into cell types of
interest such as photoreceptor cells [7–10]. The in vitro
generation of cones from patients with specific cone
disorders could thus provide an accurate model to study
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Table 1. Summary of the animal models for cone dystrophies. The table lists the animal models described in the review, compiling the
species, the name of the gene that was modified, the method of generation of the model, and the human disease targeted
Model Species Gene Method of generation Human condition Reference
pTol2:3.2 gnat2-RETGC-1 E837D
R838S
Danio rerio RETGC-1 Embryo injection and
transposase system
CORD6 [27]
rd/rd Rhode Island Red chicken Gallus gallus domesticus GC1 Spontaneous mutation LCA [35]
Rpe65R91W/R91W Mus musculus Rpe65 ES homologous recombination LCA [40]
Rpe65−/− Mus musculus Rpe65 ES homologous recombination LCA [42]
Rpe65rd12 Mus musculus Rpe65 Spontaneous mutation LCA [41]
Lrat−/− Mus musculus Lrat ES homologous recombination LCA, RP [128]
Nrl−/− Mus musculus Nrl ES homologous recombination ESCS syndrome [53]
rd7 Mus musculus Nr2e3 Spontaneous mutation ESCS syndrome [55]
Rpe65−/−;Nrl−/− Mus musculus Rpe65;Nrl Breeding of single knockout Macula region [63,65]
Rpe65R91W/R91W;Nrl−/− Mus musculus Rpe65;Nrl Breeding of single knockout Macula region [66]
Gucy2e−/− ;Nrl−/− Mus musculus Gucy2e;Nrl Breeding of single knockout Macula region [71]
Sudanian grass rat Arvicanthis ansorgei MNU and light-induced
toxicity
Macular degeneration [51,52]
Nile grass rat Arvicanthis niloticus Macula region [49]
Awassi sheep Ovis orientalis CGNA3 Spontaneous mutation ACHM [72]
Pig TgP347L, Pig-Tg N1Pet Sus scrofa RHO Pronuclear injection and
homologous recombination
RP [79]
Pig TgP23H, line 53-1 Sus scrofa, NIH minipig RHO Somatic cell nuclear transfer RP [80]
Pig ELOVL4− 790e794delAACTT Sus scrofa ELOVL4 Pronuclear injection and
homologous recombination
STDG3 [91]
Pig ELOVL4− Y270terEYFP Sus scrofa ELOVL4 Somatic cell nuclear transfer STDG3 [91]
Pig GUCY2D -E837D;R838S Sus scrofa GUCY2D Lentiviral-directed
transgenesis
CORD6 [93]
cmr1, cmr2, cmr3 Canis lupus BEST1 Spontaneous mutation Macular dystrophy [95]
XLPRA1, XPLRA2 Canis lupus RPGR Spontaneous mutation XLRP [96]
crd Canis lupus NPHP4 Spontaneous mutation LCA [98]
crd Canis lupus RPGRIP1 Spontaneous mutation LCA [101]
crd2 Canis lupus NPHP5, IBQ1 Spontaneous mutation LCA, SLSN [100]
crd3 Canis lupus ADAM9 Spontaneous mutation CORD9 [106]
Achromatopsia Alaskan Malamute Canis lupus CNGB3 Spontaneous mutation ACHM [110]
Achromatopsia German
Shorthaired Pointer
Canis lupus CNGB3 Spontaneous mutation ACHM [110]
Retinal transduced squirrel
monkey
Saimiri sciureus L-OPSIN Somatic retinal transfer Trichromacy recovery [111]
cone imbalance or cone death and to screen therapeutic
compounds. Although the creation of retina-like tissue
derived from iPSCs allows analysis of photoreceptor
generation [11–13], the production of human cones
is still poor and the process does not recapitulate the
formation of the macula or the subsequent synaptic
connecting network. In consequence, the first disadvan-
tage of these in vitro models is that so far, no culture
system enables study of the mechanisms of human
macular degeneration, especially when this loss is due
to a deficiency of neighbouring cells such as Müller
and retinal pigmented epithelial (RPE) cells. Special
effort to adapt cultures of multiple cell types would
thus be needed to mimic in vivo conditions. Second, in
some cone dystrophy cases, the time necessary to obtain
cone degeneration might not be perfectly reproducible
in vitro as the onset varies from shortly after birth
(achromatopsia) to 70 years of age (as in some patients
affected by the Stargardt diseases, see the review by
Roosing et al [4]). Third, even if this in vitro model
could be useful to screen for the potential of specific
compounds to rescue cones, it could not fully validate
the efficiency of the technological transfer in vivo or
assess for the global effect induced in the long term.
Non-mammalian cone-rich models
Retinal research benefits from a wide panel of ani-
mal models. Many gene deficiencies implied in visual
defects affect only vision which, at least in labora-
tory conditions or domestic breeding, is not required
for survival. Thus, numerous animal models have been
described following spontaneous mutations of genes
also involved in human retinal disorders [3,14,15]. Most
rodents, like most mammalians, are dichromatic and
have only two types of cones, sensitive to medium
(M-cone) and short (S-cone) wavelengths, in contrast
to primates and humans, who have three types of
cones: short (blue), medium (green), and long (L-, red)
wavelengths (Figure 1). Interestingly, birds, reptiles, and
fishes are also at least trichromatic or even tetrachro-
matic, which gives alternatives to researchers for mod-
elling cone disorders.
Among fishes, the model of choice selected for devel-
opment and physiopathology studies is the zebrafish,
thanks to its widely known genetics [16], even though
several cone physiological studies have been performed
using carp. In addition to carrying three cone types,
the zebrafish has a fourth UV-type of cone, as well
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Figure 1. Schematic representation of cone distribution in the central retina of different species. Both sections of the outer nuclear layer
and visualization of the eye fundus were schematically represented to highlight the specific cone distribution of the retina of zebrafish,
chick, mouse, sheep, pig, dog and human. Photoreceptor types are arbitrarily coloured to represent the different categories of cones
(L, M, S, and double cones) and rods. The wavelength of each photopigment is also indicated. (A) In zebrafish, in addition to S- and
UV-cones, a double cone is observed with fusion at the level of the IS of two OSs containing either L- or M-opsin. The four classes
of cones are then laid out in a regular mosaic pattern. (B) The chick retina contains five types of cones comprising a double cone (in
yellow) as well. The different types of cones are homogeneously arranged in the retina. A particular vascular extension, the pecten (red
rectangle), is apposed at the inner part of the retina. (C) The mouse retina is composed of only 3% cones, distributed throughout the retina.
A dorso-ventral gradient of cone expression is observed, with S-opsin mainly expressed in the inferior hemisphere and M-opsin in the
superior hemisphere. However, both opsins are observed in single cells in the overlapping gradient. (D) The sheep retina includes two
types of cones, with higher densities of cones in the central streak and in the dorso-temporal region. S-cones are enriched in this particular
peripheral region. Sheep have a tapetum, a membrane reflecting the light in the superior hemisphere (yellow area) except in the dorso-nasal
periphery. (E) The pig retina features two types of cones, with densities higher in the central streak. (F) The dog retina is also characterized
by two types of cones and a central streak, but recently a fovea-like region was identified with an increased number of cones and a longer
OS. Dogs also have a tapetum in the superior hemisphere (yellow area). (G) The human central retina is characterized by a region with
exclusively cones named the fovea, containing mainly L- and M-cones. S-cones are distributed in the perifovea region and in the periphery.
ONL: outer nuclear layer; OS: outer segment; black circle: optic nerve head; red lines: vessels; S: superior; I: inferior; N: nasal; T: temporal.
Source: refs 32, 72, 94, and 112–127; http://www.cvrl.org/database/text/intros/introdens.htm
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as calyceal processes, which are membrane extensions
from the apical side of the IS surrounding the basal part
of the OS [17] and are described in primate cones but
are absent in mouse cones [18]. Several external fac-
tors such as light exposure have been used to induce and
study photoreceptor degeneration [19–22]. In addition
to screening of mutagenized zebrafish stocks [23,24],
gene editing tools offer many possibilities to engineer
zebrafish models for specific genes [25]. However, the
major limitation of zebrafish models is the capacity of
the retina to regenerate, whichmay affect the parallelism
with patients [26]. For example, a dominant mutant
allele of the guanylate cyclase 2D (GUCY2D) gene
under the control of a cone promoter was used to perform
transgenesis with a transposase system [27] in order to
model the phenotype of cone–rod dystrophy (CORD6)
patients [28–30]. In these families, the first symptoms
described are decreased visual acuity, followed by loss
of colour discrimination during the first decade. In the
transgenic GUCY2D mutant zebrafish model, no early
changes in visual function (optokinetic response) were
detected, despite decreased staining of cone and rod
markers in both larva and adults. Whether the regen-
erative properties of the zebrafish retina impaired the
progression of the disease remains unknown.
Chickens are an alternative model suitable for cone
studies, thanks to the high content of cones in their
retinas [31,32]. Moreover, the embryonic stages are
easily accessible and the large size of the chick eye
during development makes them an appreciated model
for development studies [33,34]. No transgenic models
for retinal diseases have been engineered but the sponta-
neous model ofGC1 gene loss of function [35] was used
to demonstrate the efficiency of gene replacement using
lentiviral vectors [36]. A retinal detachment model
was also produced by subretinal injection of saline or
hyaluronic acid to study cone survival in this paradigm
[37]. However, the organization of the chicken vascu-
lature is different from that in humans as their retina is
avascular but with a highly glial and vascular structure
called the pecten, which is localized in the vitreous of
the eye [38,39]. Thus, the retina’s morphology appears
different between birds and mammals, as probably is
cone physiology.
Novel perspectives on rodent modelling
of cone-rich retina
Mouse and rat animal models of cone dystrophy face a
major limitation due to the absence of the highly spe-
cialized central region found in the monkey and human
retina forming the macula and the fovea (Figure 1). As
murine and rat retinas have only 3% of cone-type cells
spread within rods, they are more adapted for modelling
the peripheral primate retina, where the blue-sensing
cones are mainly distributed. For example, in the
Rpe65R91W knock-in mouse model where a mutation
encountered in patients was substituted to the murine
wild-type codon [40], S-cones were rapidly affected and
degenerated during the first months of life. The cone
loss was even more rapid in the case of complete abla-
tion of the gene (Rpe65−/− or the Rpe65rd12 spontaneous
model [41,42]) or in other chromophore-deficient mod-
els (Lrat−/− [43]). This early degeneration of S-cones is
consistent with the phenotype of patients with RPE65
p.R91W, who endure early blue cone dysfunction
in addition to rod desensitization [44]. Interestingly,
Samardzija et al demonstrated that in cases of limited
levels of chromophore in mice, rods compete with cones
for chromophore loading [45]. This observation could
explain why the peripheral human blue cones (equiva-
lent to the murine S-cones) might be more affected than
foveal cones in these patients deficient in RPE65.
In order to find rodent retinas enriched in cones, some
researchers have looked further amongst diurnal ani-
mals, which are in general richer in cones than noctur-
nal ones [46]. Examination of the retinas of Arvicanthis
ansorgei and A. niloticus, the Sudanian and Nile grass
rats, respectively, revealed a ten-fold higher number of
cones compared with Mus musculus [47–49]. As these
animals are genetically closer to mouse than the ground
squirrel (90% cones) [50], research using them can ben-
efit from many tools developed for mice (antibodies,
databases, maintenance, etc). The 30% of cones com-
posing the A. ansorgei retina were thus proposed to offer
a better model for the human macula. This model was
used to demonstrate the separate cone death succeeding
rod death in the case of MNU-induced toxicity, as well
as the high resistance of cones to stress [51,52]. How-
ever, nomodels for specific gene dysfunctions have been
described yet, limiting the studies of Arvicanthis retinas
to the use of external damaging factors.
In contrast, the deep understanding of the genetics
of retinal development in mice created opportunities to
generate mouse models deprived of rods and enriched in
cone-like cells. The genetic ablation of the Nrl transcrip-
tion factor in the Nrl−/− mouse impairs rod development
and maintains the precursor in the default cone differen-
tiation pathway [53,54]. Similar results were observed
in rd7 mice, where a retrotransposon is inserted in the
Nr2e3 gene, a downstream target of Nrl. In the retina
of rd7 mice, hybrid photoreceptors called ‘cods’, dis-
playing many characteristics of S-cones, are present but
no enhanced S-cone system is detected by electroretino-
gram (ERG) recordings [55–59]. In humans, NRL gene
variants have been identified in patients suffering from
an enhanced S-cone sensitivity syndrome. Studies in
the Nrl−/− mouse have enabled a better understand-
ing of the origin of supranormal photopic activities of
patients but have also revealed the phagocytosis defect
of Nrl−/− cone OSs, which seems consistent with imag-
ing reported in patients [60]. Moreover, transient and
partial cone degeneration was observed between 1 and
4 months in Nrl−/− mice, followed by the long-term per-
sistence of remaining cones [61]. The circulating reti-
nal current of the young adult Nrl−/− retina enriched in
cone-like cells is less demanding of oxygen compared
with aWT rod-rich retina [61,62]. Hyperoxic conditions
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are thus created and are thought to induce a remodelling
of the Nrl−/− retinal architecture with Müller cell acti-
vation, RPE atrophy, and loss of vasculature. Consistent
with this hypothesis is the work on the Rpe65−/−;Nrl−/−
double knockout mouse that showed a role for the
chromophore in the formation of rosettes in the Nrl−/−
background, because the absence of 11-cis-retinal in
the RPE65−/− background allows recovery of a normal
layered retina [63–65]. However, these mice have no
visual function, due to the absence of a chromophore,
and are thus of limited interest. Samardzija et al pro-
posed the use of the Rpe65R91W;Nrl−/−mouse as an alter-
native [66], and indeed the persistence of a 10% wt
level of RPE65 protein as well as its remaining resid-
ual activity allows efficient suppression of the forma-
tion of rosettes while maintaining a recordable reti-
nal activity [66]. Retinal markers and functional tests
also revealed that the Rpe65R91W background preserves
second- and third-order neurons (horizontal and retinal
ganglion cells) that are usually affected secondarily in
theNrl−/− background. The vasculature was also rescued
and this renders the Rpe65R91W;Nrl−/− mouse a reliable
all-cone retina model with a preserved retinal architec-
ture. In this complex genetic background, cone loss can
be studied in acute or slow degeneration processes using
MNU administration or specific ablation of phosphodi-
esterase (PDE) genes [66].
Other gene defects have been examined in this
Nrl−/− cone-only background and highlight the effi-
ciency of cone rescue after gene replacement strategies.
For example, Du et al [67] demonstrated the effi-
ciency of intra-vitreous injection of the AAV8 (Y447,
733 F) vector to target cones and restore vision in
Cnga3−/−;Nrl−/− mice. The AAV8 (Y447, 733 F) capsid
is a genetically modified capsid 8 protein which can
cross the retina from the inner side and reach the outer
part of the retina to transduce photoreceptor cells.
The authors thus validated a less damaging approach
for vector delivery to cones than subretinal injection
[67]. Similarly, Boye et al, after validation in multiple
guanylate cyclase-deficient murine models of Leber
congenital amaurosis [68–70], also demonstrated cone
rescue in the Gucy2e−/−;Nrl−/− model after subreti-
nal injection of AAV8 (Y733)-hGRK1-Gucy2e or
AAV5-hGRK1-Gucy2e vectors [71]. Taken together,
these results demonstrate how fundamental research on
the development and physiology of the rodent retina
has opened new perspectives for disease modelling and
therapy development.
Naturally-occurring cone dystrophy in sheep
The sheep retina, although having no macula, shows
two cone-enriched regions: a streak in the central part of
the retina and a dorso-temporal small area (Figure 1D).
The central region is termed the area centralis and is
composed of two cone types [short wavelength (S-cone)
and medium/long wavelength cones (M/L-cones)], but
S-cone density is particularly high in the dorso-temporal
region. In addition, a tapetum, a layer located behind
the retina, covers the dorso-temporal region with
an extension towards the nasal area. This tapetum
enhances the chance of photon capture by the pho-
toreceptors by reflecting photons back to the retina.
A naturally-occurring day blindness was observed in
the improved Awassi breed [72] and was associated with
a mutation in the gene encoding the α subunit of the
cone photoreceptor cyclic nucleotide-gated (CNGA3)
[73]. Lambs showed an almost normal rod function,
whereas ERG recorded in photopic conditions (in
which the animal is light-adapted and receives stimuli
in presence of an illuminated background) revealed a
diminished amplitude of cone responses. The pupil light
reflex was also impaired in the daytime. The presence
of a well-preserved retina during the first months of
the disease renders these animals an interesting model
for a gene therapy treatment to recover cone function
at different time points through the course of disease.
Recently, Banin et al [74] restored cone function in
these animals by AAV2/5 gene transfer.
Transgenic pigs to study retinal dystrophies
The pig retina also contains an area centralis com-
posed of around 30% cones that express M/L-opsin and
S-opsin (Figure 1E). Novel therapeutic approaches can
be tested using this model since the pig, similarly to pri-
mates and humans, presents a fully developed retina at
birth, and benefits from an immune system comparable
to the human one. Moreover, the large size of the eye
makes it particularly suitable for validating procedures
that may be suited to use in humans. Among various
strategies, pigs have been used to test retinal prosthe-
sis implants [75], cell transplantation [76,77], and vector
serotypes as well as promoter activity for gene therapy
developments [78].
Pig rod dystrophy models for studying cone
degeneration
The first transgenic (Tg) pig to model a retinal dys-
trophy was generated by pronuclear microinjection to
mimic a severe form of retinitis pigmentosa caused by
the dominant rhodopsin (RHO) gene mutation p.P347L
[79]. The 5’-upstream region of the human RHO gene
served as a promoter for the human mutated allele. This
work was then followed by the generation of TgP23H
pigs [80] using stable-transfected pig fibroblasts, which
then served for nuclear transfer. In this study, the trans-
genewas controlled by the phosphoglycerate kinase pro-
moter and the NIH miniature pig (SLAC/C haplotype)
was used. Although these mutations affect specifically
rod function and survival, these models are also interest-
ing for cone studies as cone death is observed following
rod loss. This secondary wave of photoreceptor death is
hypothesized to be related to a deficit in a survival fac-
tor secreted by rods, the rod-derived cone viability factor
© 2015 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2016; 238: 300–310
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(RdCVF [81]) and in nutrients supplied by the choroid,
the main component probably being glucose [82]. Very
recent work linked RdCVF and glucose by showing
that this factor binds cones on basigin-1, favouring glu-
cose intake [83]. This RdCVF deficit is one explanation
for the consequence of rod death on cone survival but
does not elucidate the whole mechanism governing cone
death during the late phase of retinitis pigmentosa. In
this context, the availability of large transgenic animal
models of retinal dystrophies such as pigs is a very valu-
able improvement in studying the process of cone death
and developing new therapies to inhibit this process.
In both TgP347L and TgP23H pigs, in which rod
function is severely affected, cone activity is also altered
and continuously declines during the course of the dis-
ease [79,80,84]. The TgP347L pig showed a decline
of the retinal responses measured by ERG in photopic
conditions at 4 and 87 weeks of age [79]. For the
TgP23H pig, the first time point investigated was at 14
days of age in the most severely affected animals, and
these showed an absence of the scotopic response (in
which animals are dark-adapted and receive stimuli in
a dark background in order to reveal rod function) [85].
The cone response had declined at 2 months and had
decreased to 50% at 3 months of age [80,85]. The pho-
topic response then remained at approximately 30% of
theWT response until 18–24months. Surprisingly, cone
morphology, as evidenced by electron microscopy, was
already altered during the retina’s development at E10.5
and P3, despite normal recordings in photopic condi-
tions obtained at P3 [86]. These two models clearly
reveal that cone degeneration rapidly follows rod loss,
indicating that cone protection needs to be performed at
an early stage of rod dystrophies.
Stargardt-like macular dystrophy type 3 in pigs
A juvenile form of macular degeneration termed
Stargardt-like macular dystrophy type 3 (STGD3) is
associated with mutations in the elongation of the very
long-chain fatty acids-4 gene (ELOVL4 [87]), which
codes for an enzyme of the elongase family involved
in long-chain fatty acid synthesis [88] and is mainly
expressed in rods and cones [87]. The cones in the
macula are particularly affected, in comparison to rods,
by the g.790_794delAACTT deletion (resulting in the
loss of 51 terminal amino acids); the p.Y270X mutation
or the allele bearing a double single nucleotide deletion
g.[789delT;794delT] also results in a dominant form of
the disease [89,90]. A total of 1226 injections into pig
pronuclei were performed with a construct expressing
ELOVL4 g.790_794delAACTT or a fluorescent pro-
tein (EYFP) fused at the C-terminus of the p.Y270X
variant (p.Y270terEYFP). Gene expression in both
constructs was controlled by the RHO Rho4.4 promoter
(4.4 kb fragment upstream of the rhodopsin coding
sequence, the exact origin not being indicated) [91].
The embryos were conveyed into 22 gilts, from which
three transgenic animals were generated. Concerning
the p.Y270terEYFP construct, a similar number of
embryos were prepared, but with the nuclear trans-
fer technique, and four pig lines were generated. The
expression of the transgene appeared to be preferentially
present in the cones (only one row of photoreceptors
in the area centralis positive for EYFP in the outer
part of the ONL). Nonetheless, the ERG recordings
revealed that both rod and cone functions were altered
in some animals at 14.5months. These experiments
show that the presence of truncated ELOVL4 proteins
recapitulates different features of the STGD3 disease in
pigs as it did in mice [88], thus proposing interesting
models to study the pathophysiology of this disease.
Production of a large cohort of transgenic pigs
to study CORD6
CORD6 is the most frequent dominant cone dystrophy
form in humans. The p.E837D and p.R838S variants of
the GUCY2D gene product are associated with disease
appearance [29,92]. By using a lentiviral vector encod-
ing the mutated GUCY2D cDNA controlled by the cone
arrestin promoter and injected in fertilized oocytes,
Kostic et al [93] generated three cohorts of transgenic
pigs. Around 50% of the offspring carried from one
to six copies of the transgene. No abnormal behaviour
or adverse health issues were observed in the piglets,
despite integration of the transgene into the pig genome.
A series of mobility tests based on vision were per-
formed at different ages in parallel to optical coherence
tomography (OCT) and ERG recordings to evaluate the
morphological and physiological integrity of the retina.
Interestingly, a wide range of response patterns to all
these tests was described within the transgenic group.
Although the response variability was high in the trans-
genic pigs, changes in the behaviour tests were observed
in several transgenic animals and a significant alteration
of transgenic cone activity was noticed by ERG in
comparison to WT littermates. Moreover, histology
revealed that all transgenic pig eyes had displaced cone
nuclei that localized to the OS region, indicating a
degenerative process. The overall results show that the
GUCY2D gene bearing the two disease-causing variants
p.E837D and p.R838S alters cone function and visual
performance in photopic conditions, and induces a slow
process of cone degeneration.
The variability observed among the transgenic ani-
mals is a consequence of the lentiviral transgenesis strat-
egy used and may advantageously model the variability
of the phenotypes observed in humans due to the incom-
plete penetrance of the disease. Moreover, the high per-
centage of the transgenic animal yield with the lentiviral
vector (60% in this work) allows for the design of new
experimental approaches to study the effect of dominant
mutations.
Dog models for cone dystrophies
Since 26 dog models of retinal dystrophies have
already been characterized and described in a very well
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documented review [3], we will discuss here new data
as well as dog models of cone dystrophy for which the
gene mutation leads directly or predominantly to cone
alteration. Like pigs, dogs possess an area centralis
enriched in cones. However, detailed characterization of
this region revealed that in a very small area, described
as fovea-like, there is an elevation in the number of cone
rows (from 1 to 3) and a decreased number of rod layers
from 8 to 2–3 rows. In parallel, the RGC layer almost
triples in this region, forming a dome around 200 μm
wide. Moreover, cones and rods featured elongated
segments [94]. All of these characteristics suggest that
the dog retina contains a small fovea-like structure
(Figure 1 F). These features render the dog retina very
attractive to study gene mutations affecting mainly cone
physiology and survival.
The study of two different dog models of cone dys-
trophies confirms that this fovea-like area behaves dif-
ferently from other retinal regions. In Best’s disease in
humans, the macula is first affected, although the genetic
mutation alters RPE function in general. In the BEST1
dog model [95], the first lesion observed, corresponding
to detachment of the retina from the RPE layer, appeared
in the fovea-like region [94]. This observation suggests
that the dog fovea displays a vulnerability to external
environmental stresses similar to that in the macula of
affected patients. In the dog model of human X-linked
progressive retinal atrophy 2 (XLPRA2), variants in the
RPGR gene lead to alteration of the structural cilium
connecting the IS to the OS. In humans, mutations in
the RPGR gene result in a wide range of phenotypes;
nonetheless, the macula is often severely affected. Inter-
estingly, in the dog model of RPGR alteration [96], the
fovea is also the first area affected by the mutation,
although the RPGR protein is altered in all cones. At
2 weeks of age, the cone number is already lower in
the affected dog in comparison to WT but this number
remains stable for 22 weeks. After this stable period,
both cone and rod numbers decrease in the fovea, along
the streak, and centrifugally.
These two examples provide evidence that the dog
retina is of great value for studying cone diseases that
affect the macula preferentially in humans. Several other
naturally-occurring cone diseases have also been identi-
fied in dogs for which the identification of this fovea-like
region may help to establish the first events appearing
during these diseases.
Cone dystrophies linked to cilium alteration
In standard wirehaired dachshund dogs, a mutation
in the NPHP4 gene, altering its product’s ability to
bind the RPGRIP1 cilium protein, was associated with
an early-onset cone dystrophy [97,98]. Affected dogs
showed an early-onset cone alteration at 5 weeks of
age, evidenced by ERG in photopic conditions and
using flicker stimulations [99]. In the cone rod dystro-
phy (Crd2) cone dystrophy dog, mutations in another
member of this gene family, NPHP5 (IQCB1), correlate
with cone and rod abnormal segment formation, and
progressive photoreceptor death [100]. Important
variability was observed between dogs during the
degenerative process. As expected, the mutation in
the RPGRIP1 gene found in the miniature longhaired
dachshunds [101] is also linked to retinal ciliopathy.
These dogs suffer from cone dysfunction starting at 7
weeks [102,103], but substantial variations in disease
onset and severity have been observed in certain colonies
[103,104] and not others [105]. Gene augmentation
strategies with AAV2/5 and AAV2/8 have demon-
strated the feasibility of re-establishing and maintaining
cone function in RGRIP1-deficient dogs for at least
2 years.
Considered together, it is clear that these models
recapitulate several retinal diseases observed in humans
and enable the study of a network of proteins impli-
cated in the mechanisms of ciliopathy in large animals.
These results also reveal the existence of other genetic
modifiers which remain to be identified.
Cone dystrophy and extracellular matrix proteins
Glen of Imaal terrier dogs carry a deletion in the
ADAM9 gene resulting in the absence of exons 15 and
16 in the transcript which alters the protein’s func-
tion [106]. Longitudinal studies (using different dogs)
showed that the retinal activity declines with time,
affecting both cone and rod functions. These data are
in accordance with the progressive loss of the two pho-
toreceptor populations. This animal model reproduces
the major features observed in CORD9 patients and
contrasts with the knockout mice that display subtle
morphological changes within the RPE/photoreceptor
interactions [107].
Achromatopsia
In Alaskan Malamute dogs, a cone dystrophy was
characterized by an early loss of day vision in bright
light and normal vision in dim light [108]. Alteration of
day vision was detectable between 8 and 12 weeks, and
cone function was absent in young adults, as evidenced
by red light stimuli. Rod function remained normal
during the dog’s lifespan. Electron microscopy analy-
ses revealed that disorganization of the cone lamellar
discs was already present in young dogs [109]. The
high severity of the phenotype is correlated with total
absence of the expression of CNGB3, which codes
for the cone-specific channel subunit beta-3 [110]. A
missense mutation in CNGB3 was also associated with
cone vision loss in German shorthaired pointer dogs.
In these models, CNGB3 loss is causative for the day
blindness observed in these dogs, similar to the majority
of human achromatic patients [4].
Creating trichromatic vision in the monkey
In the adult squirrel monkey strain (Saimiri sciureus),
which has calyceal processes as do humans [18], the
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females have trichromatic vision (like humans), with
cones expressing M, L, and S-opsins, whereas the males
are dichromatic, with absence of the L-opsin. Man-
cuso et al [111] investigated whether the adult brain
of a male monkey has enough plasticity to integrate
the signal of a new chromophore to generate trichro-
matic vision, by transferring the L-opsin cDNA via
AAV2/5 into male M-cones to extend their spectral
domain to catch signals from longer wavelengths. This
manipulation allowed the monkey not only to recog-
nize a new subtle colour pattern among a grey back-
ground, but also to discriminate a blue-green (wave-
length 490 nm) form from a red-violet background
(wavelength 499 nm), a task which a non-treated ani-
mal failed. These results showed that the adult eye and
brain can be reprogrammed for trichromatic vision and
that the endogenous neural wiring is sufficient to inte-
grate this new signal to augment environment percep-
tion. This new discrimination between ‘red’ and ‘green’
may be possible because not all red cones were trans-
duced with the green opsin. The relative level of expres-
sion of green versus red opsin could also play a role
in this acquired colour discrimination. This astonishing
work opens up new perspectives for vision rehabilita-
tion and new treatments via gene transfer not only for
achromatopsia.
Perspectives
Gene transfer has been proved to be efficient for the
generation of transgenic animal models of different
species. However, the main target for this approach is
the study of the effect of genetic variants associated
with dominant diseases. With the evolution of the gene
editing technologies such as the CRISPR/Cas9 system,
transgenesis will certainly be bolstered by models for
recessive diseases enlarging the panel of molecular
pathways available for research. So far, the different
large animal models have mainly been used to make or
affine genotype/phenotype correlations. In the future,
the availability of several of these models will help
to establish the molecular mechanism of diseases and
allow us to better comprehend the biological differences
between rodents and higher vertebrates, as well as
prepare for the scale-up of new therapeutic approaches.
In this context, large animals such as pigs, with a high
rate of reproduction and less ethical concerns from the
public, will have an advantage. The use of large animal
models will definitively have an important societal
impact for regenerative medicine and drug screening
before launching a clinical trial.
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